A Comparison of Globally Applied Prognostic Risk Groups and the Prevalence of Metastatic Disease on Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer

Luining, Wietske I.; Boevé, Liselotte M.S.; Hagens, Marinus J.; Meijer, Dennie; de Weijer, Tessa; Ettema, Rosemarijn H.; Knol, Remco J.J.; Roeleveld, Ton A.; Srbljin, Sandra; Weltings, Saskia; Koppes, Jose C.C.; van Moorselaar, Reindert J.A.; van Leeuwen, Pim J.; Cysouw, Matthijs C.F.; Oprea-Lager, Daniela E.; Vis, André N.

doi:10.1016/j.euo.2024.04.005

European Urology Oncology

2024

DOI: 10.1016/j.euo.2024.04.005

|View full text |Cite

A Comparison of Globally Applied Prognostic Risk Groups and the Prevalence of Metastatic Disease on Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer

Wietske I. Luining,

Liselotte M.S. Boevé,

Marinus J. Hagens

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

The appropriateness of PSMA PET/CT in newly diagnosed unfavorable intermediate-risk prostate cancer patients—towards a tumor volume-based risk stratification

Hagens,

Luining,

Boevé

et al. 2024

Prostate Cancer Prostatic Dis

View full text Add to dashboard Cite

The appropriateness of PSMA PET/CT in newly diagnosed unfavorable intermediate-risk prostate cancer patients—towards a tumor volume-based risk stratification

Hagens,

Luining,

Boevé

et al. 2024

Prostate Cancer Prostatic Dis

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

A Comparison of Globally Applied Prognostic Risk Groups and the Prevalence of Metastatic Disease on Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer

Cited by 1 publication

References 28 publications

The appropriateness of PSMA PET/CT in newly diagnosed unfavorable intermediate-risk prostate cancer patients—towards a tumor volume-based risk stratification

The appropriateness of PSMA PET/CT in newly diagnosed unfavorable intermediate-risk prostate cancer patients—towards a tumor volume-based risk stratification

Contact Info

Product

Resources

About